共 50 条
- [41] Re: Reduction of Urgency Severity is the Most Important Factor in the Subjective Therapeutic Outcome of Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Editorial CommentJOURNAL OF UROLOGY, 2017, 198 (04): : 748 - 749Wein, Alan J.
- [42] Re: Urinary Retention Rates after Intravesical OnabotulinumtoxinA Injection for Idiopathic Overactive Bladder in Clinical Practice and Predictors of this Outcome Editorial CommentJOURNAL OF UROLOGY, 2016, 195 (03): : 685 - 686Wein, Alan J.
- [43] Re: Antibiotic Use in Long-Term Care Facilities Editorial CommentJOURNAL OF UROLOGY, 2012, 187 (06): : 2123 - 2123Griebling, Tomas L.
- [44] Promising Long-Term Outcome of Bladder Autoaugmentation in Children with Neurogenic Bladder Dysfunction EDITORIAL COMMENTJOURNAL OF UROLOGY, 2013, 190 (05): : 1875 - 1875Dewan, Paddy
- [45] Long-term compliance and results of intravesical botulinum toxin A injections in male patientsNEUROUROLOGY AND URODYNAMICS, 2017, 36 (07) : 1855 - 1859Rahnama'i, Mohammad S.Marcelissen, Tom A. T.Brierley, BeverleySchurch, Brigittede Vries, Peter
- [46] Third-line treatment for overactive bladder: should mirabegron be tried before intravesical botulinum toxin A therapy?INTERNATIONAL UROGYNECOLOGY JOURNAL, 2015, 26 (03) : 367 - 372Balachandran, AswiniCurtiss, NatashaBasu, MayaDuckett, Jonathan
- [47] Third-line treatment for overactive bladder: should mirabegron be tried before intravesical botulinum toxin A therapy?International Urogynecology Journal, 2015, 26 : 367 - 372Aswini BalachandranNatasha CurtissMaya BasuJonathan Duckett
- [48] The long-term use of botulinum toxin for adult strabismusJOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, 1998, 35 (01) : 9 - 16Horgan, SELee, JPBunce, C
- [49] Long-Term follow-up of intravesical onabotulinum toxin-a injections in patients with idiopathic overactive bladder: clinical outcomes and persistence to treatmentNEUROUROLOGY AND URODYNAMICS, 2019, 38 : S35 - S36Gubbiotti, MarilenaGiannantoni, Antonella
- [50] Re: Long-Term Outcomes of Intravesical Dimethyl Sulfoxide/Heparin/Hydrocortisone Therapy for Interstitial Cystitis/Bladder Pain Syndrome Editorial CommentJOURNAL OF UROLOGY, 2018, 199 (04): : 897 - 898Wein, Alan J.